Page 17 - AN-4-3

Advanced Neurology Stem cell therapy in stroke treatment: Advances and prospects

Conflict of interest 8. Aizman I, Vinodkumar D, McGrogan M, Bates D. Cell injury-
induced release of fibroblast growth factor 2: Relevance to
The authors declare that they have no competing interests. intracerebral mesenchymal stromal cell transplantations.
Stem Cells Dev. 2015;24(12):1623-1634.
Author contributions
doi: 10.1089/scd.2015.0083
Conceptualization: Aminu Auwal Umar, Khadga Raj Aran 9. Dao M, Tate CC, McGrogan M, Case CC. Comparing the
Writing – original draft: Ibrahim Isyaku, Shabani Ally Rajab angiogenic potency of naïve marrow stromal cells and
Writing – review & editing: Aminu Auwal Umar, Khadga Notch-transfected marrow stromal cells. J Transl Med.
Raj Aran, Shabani Ally Rajab 2013;11:1-1.

Ethics approval and consent to participate doi: 10.1186/1479-5876-11-81
Not applicable. 10. Jones SP, Baqai K, Clegg A, et al. Stroke in India: A systematic
review of the incidence, prevalence, and case fatality. Int J
Consent for publication Stroke. 2022;17(2):132-140.
doi: 10.1177/17474930211027834
Not applicable.
11. Feigin VL, Stark BA, Johnson CO, et al. Global, regional, and
Availability of data national burden of stroke and its risk factors, 1990–2019:
A systematic analysis for the Global Burden of Disease Study
Data are available upon reasonable request. 2019. Lancet Neurol. 2021;20(10):795-820.

References doi: 10.1016/S1474-4422(21)00252-0
1. Donkor ES. Stroke in the 21 century: A snapshot of the 12. Kamalakannan S, Gudlavalleti AS, Gudlavalleti VS,
st
burden, epidemiology, and quality of life. Stroke Res Treat. Goenka S, Kuper H. Incidence & prevalence of stroke in India:
2018;2018:3238165. A systematic review. Indian J Med Res. 2017;146(2):175-185.
doi: 10.1155/2018/3238165 doi: 10.4103/ijmr.IJMR_516_15
13. Kolios G, Moodley Y. Introduction to stem cells and
2. Kuriakose D, Zhicheng X. Pathophysiology and treatment of
stroke: Present status and future perspectives. Int J Mol Sci. regenerative medicine. Respiration. 2012;85(1):3-10.
2020;21(20):7609. doi: 10.1159/000345615
doi: 10.3390/ijms21207609 14. Lu F, Zhang Y. Cell totipotency: Molecular features,
induction, and maintenance. Natl Sci Rev. 2015;2(2):217-225.
3. Zhang C, Kasner S. Diagnosis, prognosis, and management
of cryptogenic stroke. F1000Res. 2016;5:F1000 doi: 10.1093/nsr/nwv009
Faculty Rev-168. 15. De Miguel MP, Fuentes-Julián S, Alcaina Y. Pluripotent stem
doi: 10.12688/f1000research.7384.1 cells: Origin, maintenance and induction. Stem Cell Rev.
2010;6:633-649.
4. Soto-Cámara R, González-Bernal JJ, González-Santos J,
Aguilar-Parra JM, Trigueros R, López-Liria R. Knowledge doi: 10.1007/s12015-010-9170-1
on signs and risk factors in stroke patients. J Clin Med. 16. Hoang DM, Pham PT, Bach TQ, et al. Stem cell-based
2020;9(8):2557. therapy for human diseases. Sig Transduct Target Ther.
doi: 10.3390/jcm9082557 2022;7(1):1-41.
5. Grefkes C, Fink GR. Recovery from stroke: Current concepts doi: 10.1038/s41392-022-01134-4
and future perspectives. Neurol Res Pract. 2020;2(1):17. 17. Watt FM, Driskell RR. The therapeutic potential of stem cells.

doi: 10.1186/s42466-020-00060-6 Philos Trans R Soc Lond B Biol Sci. 2010;365(1537):155-163.
6. Moskowitz MA, Lo EH, Iadecola C. The science of doi: 10.1098/rstb.2009.0149
stroke: Mechanisms in search of treatments. Neuron. 18. Cerneckis J, Cai H, Shi Y. Induced pluripotent stem
2010;67(2):181-98. cells (iPSCs): Molecular mechanisms of induction and
doi: 10.1016/j.neuron.2010.07.002 applications. Sig Transduct Target Ther. 2024;9(1):112.
7. Borlongan CV, Koutouzis TK, Jorden JR, et al. Neural doi: 10.1038/s41392-024-01809-0
transplantation as an experimental treatment modality for 19. Liu XY, Yang LP, Zhao L. Stem cell therapy for Alzheimer’s
cerebral ischemia. Neurosci Biobehav Rev. 1997;21(1):79-90. disease. World J Stem Cells. 2020;12(8):787.
doi: 10.1016/0149-7634(95)00063-1 doi: 10.4252/wjsc.v12.i8.787

Volume 4 Issue 3 (2025) 11 doi: 10.36922/an.5582